发明授权
US08076356B2 Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors
有权
三唑并吡啶基硫烷基衍生物作为P38映射激酶抑制剂
- 专利标题： Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors
- 专利标题（中）： 三唑并吡啶基硫烷基衍生物作为P38映射激酶抑制剂
-
申请号： US12371719申请日： 2009-02-16
-
公开(公告)号： US08076356B2公开(公告)日： 2011-12-13
- 发明人: John Paul Mathias , David Simon Millan , Russell Andrew Lewthwaite , Christopher Phillips
- 申请人： John Paul Mathias , David Simon Millan , Russell Andrew Lewthwaite , Christopher Phillips
- 申请人地址： US NY New York
- 专利权人： Pfizer Inc.
- 当前专利权人： Pfizer Inc.
- 当前专利权人地址： US NY New York
- 代理商 A. David Joran; John A. Wichtowski; Robert T. Ronau
- 优先权： GB0418015.4 20040812
- 主分类号： A61K31/437
- IPC分类号： A61K31/437 ; A61P11/06
摘要：
A compound of formula (I), or a pharmaceutical acceptable salt and/or solvate (including hydrate) thereof; and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.
公开/授权文献
信息查询
IPC分类:
